文献速递青光眼

血清尿酸水平与青光眼的关联:LifeLines队列与英国生物银行结果

Associations Between Serum Uric Acid Levels and Glaucoma: Results From the LifeLines Cohort and UK Biobank.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

研究分析了LifeLines队列7443名和英国生物银行90107名≥55岁参与者,评估血清尿酸与原发性开角型青光眼的关联。英国生物银行中尿酸每升高0.1 mM与青光眼 odds 增加相关(OR=1.06,95%CI=1.02-1.11,P=0.007),但LifeLines队列无关联。遗传分析未发现共享遗传相关性或因果关系,提示尿酸可能反映系统性氧化应激而非直接致病。

要点

  • 英国生物银行中血清尿酸每升高0.1 mM,青光眼 odds 增加6%(OR=1.06,95%CI=1.02-1.11,P=0.007)。
  • LifeLines队列未观察到尿酸与青光眼的关联,meta分析结果与英国生物银行一致。
  • 遗传相关、多基因风险评分和孟德尔随机化分析均不支持尿酸与青光眼存在因果或共享遗传基础。

核心结论

  • 血清尿酸升高与青光眼存在表型关联,但遗传分析不支持因果联系,尿酸可能反映系统性氧化应激而非直接参与青光眼发病。

研究设计与样本

  • 基于LifeLines队列7443名和英国生物银行90107名≥55岁参与者的观察性研究,采用logistic回归、meta分析、遗传相关、多基因风险评分和两样本孟德尔随机化分析。

主要发现

  • 英国生物银行全调整模型中,血清尿酸每升高0.1 mM,青光眼 odds 比OR=1.06(95%CI=1.02-1.11,P=0.007),meta分析结果一致。
  • LifeLines队列中未观察到血清尿酸与青光眼的关联。
  • 遗传分析未发现尿酸与青光眼之间存在共享遗传相关性或因果关系。
  • 尿酸多基因风险评分与青光眼 odds 无关,青光眼多基因风险评分与血清尿酸水平无关。

临床怎么用

  • 血清尿酸升高可作为青光眼风险的表型标志之一,但不支持通过降尿酸直接预防或治疗青光眼。
  • 对高尿酸血症患者进行青光眼筛查时,应结合其他危险因素综合评估,不宜仅凭尿酸水平判断因果。

局限性

  • 青光眼状态基于问卷和ICD代码确定,可能存在错分偏倚。
  • 研究仅纳入≥55岁人群,结论外推至其他年龄组需谨慎。
  • 两个队列结果不一致,LifeLines队列样本量较小且未发现关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to investigate the association between serum uric acid (UA) levels and primary open-angle glaucoma (POAG), and to explore potential genetic links and causal relationships using large population-based cohorts. METHODS: We analyzed data from 7443 participants in the LifeLines cohort and 90,107 participants in the UK Biobank, all aged ≥55 years. Glaucoma status was determined based on questionnaires and International Classification of Diseases (ICD) codes. Logistic regression was used to assess the association between serum UA levels and glaucoma, adjusting for demographic, clinical, and lifestyle covariates. Meta-analysis was performed to combine results across cohorts. Genetic correlation, polygenic risk score (PRS), and two-sample Mendelian randomization (MR) analyses were conducted to evaluate shared genetic architecture and causality. RESULTS: Higher serum UA levels were significantly associated with increased odds of glaucoma in the UK Biobank (per 0.1 mM increase, odds ratio [OR] = 1.06, 95% confidence interval [CI] = 1.02-1.11, P = 0.007 in the fully adjusted model), with consistent findings in meta-analysis. No association was observed in the LifeLines cohort. Genetic analyses revealed no evidence of shared genetic correlation or causality between UA and glaucoma. The UA PRS was not associated with glaucoma odds, and the glaucoma PRS showed no association with serum UA levels. CONCLUSIONS: Elevated serum UA levels were phenotypically associated with glaucoma, but genetic analyses did not support a causal link. UA may reflect systemic oxidative stress rather than directly contribute to glaucoma pathogenesis. Further studies are needed to clarify underlying mechanisms and clinical relevance.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Liu W, Guo R, Song M, et al. Associations Between Serum Uric Acid Levels and Glaucoma: Results From the LifeLines Cohort and UK Biobank. Invest Ophthalmol Vis Sci. 2026. PMID: 42370639. doi:10.1167/iovs.67.6.57

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。